<unk>  application can cause mild skin irritation and burning.<unk>  has little systemic absorption, and is considered safe for topical use in adults and children over the age of two months. The FDA has assigned it as pregnancy category B. Animal studies have shown no effects on fertility or teratogenicity, but studies in humans have not been performed. The excretion of<unk>  in breastmilk is unknown, and it is recommended that breastfeeding be temporarily discontinued during treatment. Skin reactions are uncommon. Excessive exposure to<unk>  can cause nausea, headache, muscle weakness, excessive salivation, shortness of breath, and seizures. Worker exposure to the chemical can be monitored by measurement of the urinary metabolites, while severe overdose may be confirmed by measurement of<unk>  in serum or blood plasma.<unk>  does not present any notable genotoxicity or immunotoxicity in humans and farm animals, but is classified by the EPA as a likely human carcinogen when ingested, based on reproducible studies in which mice fed<unk>  developed liver and lung tumors.
Permethrin
Tetramethrin
Cypermethrin
Quarantine
Deltamethrin
Dapsone
K-Quarantine
Scyllatoxin